Navin Fluorine International Limited · NSE:NAVINFLUOR
Navin Fluorine International — Investor Presentation (August 2026)
28 slides from Navin Fluorine International's investor presentation, Aug 17, 2026
Slide 1: Intimation of Schedule of Analyst / Institutional Investor Meet
August 17, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (East), Mumbai 400001 Mumbai 400051 Scrip Code: 532504 Symbol: NAVINFLUOR Dear Sir / Madam, Subject: Intimation of Schedule of Analyst / In
Slide 2: Investor Presentation
Investor Presentation 5th August 2026
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 4: Q1 FY27 – Performance highlights
Q1 FY27 – Performance highlights Business Highlights SALES Operating EBITDA Rs. 1,045.1 Cr Rs. 357.1 Cr Y-O-Y REVENUE GROWTH +44% YoY +11% QoQ +73% YoY +11% QoQ HPP 33% Specialty 48% Operating EBITDA Margin Operating PBT CDMO 82% 34.2 % Rs. 283.3 Cr +566 bps YoY -8 bps QoQ +101% YoY +13% QoQ Consoli
Slide 5: Q1 FY27 – Sustainable growth
Q1 FY27 – Sustainable growth Revenues Operating EBITDA Rs. Crs Rs. Crs 1,045 938 892 357 308 321 725 758 701 246 606 207 179 147 Q3 FY25 Q4 FY25 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Q3 FY25 Q4 FY25 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Operating PBT PAT Rs. Crs Rs. Crs 283 243 251 243 213 179 185 141 148
Slide 6: Business Vertical - HPP
Business Vertical - HPP Revenue In Rs. Crs Key Highlights +33% 540 ✓ Revenue growth led by volume and higher realisations 407 ✓ Pricing environment for HFC continues to be constructive; increasing interest for contractual offtakes in new capacities ✓ AHF facility commenced operations in Q4 FY26 and
Slide 7: Business Vertical - Specialty Chemicals
Business Vertical - Specialty Chemicals Revenue In Rs. Crs Key Highlights +48% 325 ✓ Sustained growth underpinned by strong order visibility ✓ Product pipeline continues to remain strong, with meaningful scale-up across 219 existing molecules and a strong line-up of new launches ✓ Chemours project i
Slide 8: Business Vertical - CDMO
Business Vertical - CDMO Revenue In Rs. Crs Key Highlights +82% ✓ Strong momentum continues, backed by order book 180 ✓ Continued deeper engagement with European CDMO major. Supported by: 99 • Increasing demand for existing molecule • Expanding our footprint in their supply chain ✓ Board had already
Slide 9: Incubating advanced materials
Incubating advanced materials Putting our strategy into action for developing a new high growth, high margin business vertical for the future. Building on core fluorination capabilities, the vertical will focus on niche applications in high growth sunrise sector – Data Centers, Electronics, Defence
Slide 10: New capex
New capex Advanced Materials cGMP4* To set up adoption capacities for Initiated today, Phase II - cGMP4 capex of Capex Details Advanced Materials Rs. 125 Crs • Incubate new value accretive business • Increasing demand for existing vertical as a future growth driver molecule of European CDMO major. C
Slide 11: Ongoing capex program
Ongoing capex program HFC MPP Chemours Project Renewable power project Additional HFC capacity De-bottlenecking MPP Initial commercial capacity Investment in SPV for setting Capex equivalent upto 15,000 MTPA capacity at Dahej to support for manufacturing to enable up of hybrid power plant Details of
Slide 12: Consolidated Profitability Statement
Consolidated Profitability Statement Particulars (Rs. Crs.) Q1 FY27 Q1 FY26 Y-o-Y Change Q4 FY26 Q-o-Q Change FY26 FY25 Y-o-Y Change Net Revenue from Operations 1,045.08 725.40 44% 937.71 11% 3,313.90 2,349.38 41% Raw Material 449.75 307.71 388.07 1,376.40 1,038.62 Employee Expenses 86.57 77.57 81.0
Slide 13: Standalone Profitability Statement
Standalone Profitability Statement Particulars (Rs. Crs.) Q1 FY27 Q1 FY26 Y-o-Y Change Q4 FY26 Q-o-Q Change FY26 FY25 Y-o-Y Change Net Revenue from Operations 694.68 542.95 28% 626.51 11% 2,301.84 1,686.81 36% Raw Material 292.40 239.44 276.24 1,026.29 777.70 Employee Expenses 62.43 54.61 59.12 220.
Slide 14: Company Overview
iN NAVIN FLUORINE International Limited Company Overview
Slide 15: Innovating with Purpose
Because innovation creates its greatest impact when it is guided by purpose. Innovation has been at the heart of Navin INNOVATING withPURPOSE Fluorine's nearly six-decade journey. From pioneering fluorochemistry capabilities to developing advanced materials, pharmaceutical solutions, specialty chemi
Slide 16: Building value through scale, innovation & partnerships
Building value through scale, innovation & partnerships PRESENCE ACROSS 3P STRATEGY 3 3 3 Geographies Business Verticals R & D Centres 4 4 Countries Manufacturing Units Products Platform OUR BUSINESSES High Performance Speciality Contract Development Partnerships Products (HPP) Chemicals and Manufac
Slide 17: Demonstrated excellence across businesses
Demonstrated excellence across businesses 6 Decades One of the first Only Indian of expertise in fluorine companies to establish a manufacturer of chemistries refrigerant business in India hydrofluoroolefins (HFO) Amongst India’s One of the largest BF3 World-class CDMO largest producers of manufactu
Slide 18: Our winning edge
Our winning edge Building Trusted Solutions for Life Integrated Reputed Brand Mafron Rich Legacy Fluorine Provider Strategic Committed to Diversified Prominent Partnerships ESG Portfolio Clientele World-class Credible Strong Global Thriving Infrastructure Certifications Presence Workforce
Slide 19: Rooted in 3P strategy
Rooted in 3P strategy Products Diversified portfolio that Platform includes fluorine based intermediates, specialty chemicals and inorganic Prioritising owning of specific 3P Focus Partnerships chemicals technologies and chemistries that serve as building blocks (BB) Capacity for various business ap
Slide 20: Strengthening innovation and R&D capabilities
Strengthening innovation and R&D capabilities Key R&D Differentiators 3 Modern R&D Centres RESEARCH FOCUSSED BACKWARD INTEGRATION Focussed on research-driven Integrating high-end fluorine Navin Research & Navin Molecular R&D innovation to develop complex reagents enables cost-effective Innovation Ce
Slide 21: Committed to Sustainable Value Creation
Committed to Sustainable Value Creation At Navin Fluorine, sustainability defines how we operate and grow. Our structured Environment, Social and Governance (ESG) framework is guided by the principles of Responsible Care (RC) and Pharmaceutical Supply Chain Initiative (PSCI). With accountability, tr
Slide 22: Progress towards our sustainability goals
Progress towards our sustainability goals ESG Goals Progress on ESG Targets in FY 2025-26 Environmental Social Governmance Environmental Social Governmance 100% 10% 100% 100% 3.94% 89.24% compliance with EPR compliance achieved with diversity in the Company workplace diversity in % resolution of req
Slide 23: Governance framework
Governance framework Board Demographics Meetings Board Independence during Highly FY 2026 engaged 6 of 10 60% Directors are Board 17 Independent actively involved in NFIL’s Board Committee strategic transformation 58 years median Directors’ age 8 Board 80% 8 of 10 Directors are Highly Experienced No
Slide 24: Diversity of thought and experience
Diversity of thought and experience Mr. Vishad P. Mafatlal (Chairman) He is an accomplished industrialist with varied experience of 29+ years in the field of textiles Ms. Apurva S. Purohit (Independent Director) and chemicals. He has a Bachelor of Science degree in Economics from the University of S
Slide 25: Governance framework: policies, practices & protocols
Governance framework: policies, practices & protocols Composition of the Statutory Committees as on March 31, 2026 Structured policies and processes addressed Out of 4 Members of the Audit Committee, investor grievances 3 are Independent and 1 Non-Executive Reported NO Accepted all the resolutions p
Slide 26: Creating lasting social impact through CSR
Creating lasting social impact through CSR “The intelligent way to be selfish is to work for the welfare of others” The Dalai Lama SHRI SADGURU SEVA OLYMPIC GOLD BLIND PEOPLE’S CSR FOCUS AREAS SANGH TRUST QUEST ASSOCIATION Health Sports Sustainable Livelihood SHAKTI CHARUTAR AROGYA SIR J. J. HOSPITA
Slide 27: Track record of progressive dividends
Track record of progressive dividends Dividend as % of Face Value Special Final Interim Payout %* 750% 750% 755% 150% 600% 600% 550% 550% 550% 500% 430% 150% 600% 150% 390 350% 350% 350% 300% 300% 315% 75% 200% 180% 210% 160% 160% 400% 140% 150% 150% 130% 325% 110% 65% 75% 85% 85% 250% 250% 250% 250
Slide 28: For further information, please contact
For further information, please contact: Navin Fluorine International Ltd. CIN : L24110MH1998PLC115499 Mr. Anish Ganatra Chief Financial Officer anish.ganatra@nfil.in www.nfil.in Investor Relations Advisors: MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pensi
Navin Fluorine International — Investor Presentation (August 2026) on 6ix